Kalsec and Infinome in partnership to commercialise precision fermentation
Image: Shutterstock/Microgen
Infinome Biosciences and Kalsec have entered into a partnership to develop and commercialise multiple precision fermentation products.
The partnership will deliver naturally produced ingredients with superior quality and consistency, in the most sustainable way possible, the companies said.
Through advanced technology and processes, Infinome is creating sustainable manufacturing solutions for Kalsec.
Infinome’s GenoScaler is a proprietary, ultra-high-throughput, CRISPR-enabled strain engineering platform designed to “rapidly optimise” microbial strains with vastly improved traits and productivities. Infinome will employ GenoScaler to develop ingredient-producing strains and provide Kalsec with these ingredients in food applications.
Kalsec said its long history and expertise in creating natural products and solutions for the food and beverage industry will enable it to maximise the benefits of Infinome’s microbial strain engineering platform. The spice and herb extracts company added that close working with customers, and a development team at Kalsec, has identified “multiple large product opportunities”.
R&D teams at Infinome will work with Kalsec to develop sustainable biomanufacturing processes through accelerated strain engineering and process development.
“The lens used to select projects include sustainability, efficiency, and enabling the use of more natural products through new production practices,” said Dr. Scott Nykaza, Kalsec CEO. “We have already embraced using Infinome’s ground-breaking technology to develop more products in our pipeline to deliver sustainable improvements for our customers.”
“Infinome’s GenoScaler is a complete, end-to-end microbial manufacturing platform based on several breakthrough technology developments,” said Dr. Richard Fox, Infinome co-founder and CEO/CTO. “Our goal at Infinome is to enable more companies to access the bioeconomy by accelerating the development and reducing the risk and complexity of biomanufacturing. Through advanced technology, strategy, and processes, we are helping to create sustainable solutions with long-term partners like Kalsec.”
